Effects of adding a neurokinin-1 receptor antagonist to 5 mg olanzapine, a 5-hydroxytryptamine-3 receptor antagonist, and dexamethasone for preventing carboplatin-induced nausea and vomiting: a propensity score-matched analysis

被引:0
|
作者
Senri Yamamoto
Hirotoshi Iihara
Ryuji Uozumi
Hitoshi Kawazoe
Kazuki Tanaka
Yukiyoshi Fujita
Masakazu Abe
Hisao Imai
Masato Karayama
Yoh Hayasaki
Chiemi Hirose
Takafumi Suda
Kazuto Nakamura
Akio Suzuki
Yasushi Ohno
Ken-ichirou Morishige
Naoki Inui
机构
[1] Gifu University Hospital,Department of Pharmacy
[2] Gifu Pharmaceutical University,Laboratory of Pharmacy Practice and Social Science
[3] Kyoto University Graduate School of Medicine,Department of Biomedical Statistics and Bioinformatics
[4] Keio University Faculty of Pharmacy,Division of Pharmaceutical Care Sciences, Center for Social Pharmacy and Pharmaceutical Care Sciences
[5] Keio University Graduate School of Pharmaceutical Sciences,Division of Pharmaceutical Care Sciences
[6] Hamamatsu University School of Medicine,Second Division, Department of Internal Medicine
[7] Division of Pharmacy,Division of Gynecology
[8] Gunma Prefectural Cancer Center,Department of Obstetrics and Gynecology
[9] Shizuoka Cancer Center,Division of Respiratory Medicine
[10] Hamamatsu University School of Medicine,Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center
[11] Gunma Prefectural Cancer Center,Department of Clinical Oncology
[12] Saitama Medical University,Department of Obstetrics and Gynecology
[13] Hamamatsu University School of Medicine,Department of Gynecology
[14] Gifu University Graduate School of Medicine,Department of Cardiology and Respiratory Medicine
[15] Gunma Prefectural Cancer Center,Department of Clinical Pharmacology and Therapeutics
[16] Gifu University Graduate School of Medicine,undefined
[17] Hamamatsu University School of Medicine,undefined
来源
BMC Cancer | / 22卷
关键词
Antiemetics; Carboplatin; Dexamethasone; Nausea; Neurokinin-1 receptor antagonist; Olanzapine; Vomiting; 5-hydroxytryptamine-3 receptor antagonists;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 41 条
  • [1] Effects of adding a neurokinin-1 receptor antagonist to 5 mg olanzapine, a 5-hydroxytryptamine-3 receptor antagonist, and dexamethasone for preventing carboplatin-induced nausea and vomiting: a propensity score-matched analysis
    Yamamoto, Senri
    Iihara, Hirotoshi
    Uozumi, Ryuji
    Kawazoe, Hitoshi
    Tanaka, Kazuki
    Fujita, Yukiyoshi
    Abe, Masakazu
    Imai, Hisao
    Karayama, Masato
    Hayasaki, Yoh
    Hirose, Chiemi
    Suda, Takafumi
    Nakamura, Kazuto
    Suzuki, Akio
    Ohno, Yasushi
    Morishige, Ken-ichirou
    Inui, Naoki
    [J]. BMC CANCER, 2022, 22 (01)
  • [2] Efficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapy
    Hesketh, Paul J.
    Schnadig, Ian D.
    Schwartzberg, Lee S.
    Modiano, Manuel R.
    Jordan, Karin
    Arora, Sujata
    Powers, Dan
    Aapro, Matti
    [J]. CANCER, 2016, 122 (15) : 2418 - 2425
  • [3] EFFICACY AND SAFETY OF GRANISETRON, A SELECTIVE 5-HYDROXYTRYPTAMINE-3 RECEPTOR ANTAGONIST, IN THE PREVENTION OF NAUSEA AND VOMITING INDUCED BY HIGH-DOSE CISPLATIN
    NAVARI, RM
    KAPLAN, HG
    GRALLA, RJ
    GRUNBERG, SM
    PALMER, R
    FITTS, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (10) : 2204 - 2210
  • [4] Comparison of netupitant/palonosetron with 5-hydroxytryptamine-3 receptor antagonist in preventing of chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation
    Zhang, Hang
    Zeng, Qiang
    Dong, Tian
    Chen, Xinchuan
    Kuang, Pu
    Li, Jian
    Wu, Qiuhui
    Liu, Ting
    Niu, Ting
    Liu, Zhigang
    Ji, Jie
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [5] Efficacy of the oral neurokinin-1 receptor antagonist aprepitant for nausea and vomiting induced by cisplatin and carboplatin in Japanese patients with gynecological cancer
    Ikeda, Masae
    Shida, Masako
    Hirasawa, Takeshi
    Muramatsu, Toshinari
    Mikami, Mikio
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2017, 43 (10) : 1613 - 1620
  • [6] Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting: A Network Meta-Analysis
    Zhang, Yaxiong
    Yang, Yunpeng
    Zhang, Zhonghan
    Fang, Wenfeng
    Kang, Shiyang
    Luo, Youli
    Sheng, Jin
    Zhan, Jianhua
    Hong, Shaodong
    Huang, Yan
    Zhou, Ningning
    Zhao, Hongyun
    Zhang, Li
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (02)
  • [7] 5-Hydroxytryptamine-3 receptor antagonist and dexamethasone as prophylaxis for chemotherapy-induced nausea and vomiting during moderately emetic chemotherapy for solid tumors: a multicenter, prospective, observational study
    Reiko Matsui
    Kenichi Suzuki
    Tomomi Takiguchi
    Makoto Nishio
    Takeshi Koike
    Toshinobu Hayashi
    Takashi Seto
    Yuki Kogure
    Naoyuki Nogami
    Kimiko Fujiwara
    Hiroyasu Kaneda
    Tomohiko Harada
    Satoru Shimizu
    Masashi Kimura
    Hirotsugu Kenmotsu
    Mototsugu Shimokawa
    Koichi Goto
    [J]. BMC Pharmacology and Toxicology, 21
  • [8] 5-Hydroxytryptamine-3 receptor antagonist and dexamethasone as prophylaxis for chemotherapy-induced nausea and vomiting during moderately emetic chemotherapy for solid tumors: a multicenter, prospective, observational study
    Matsui, Reiko
    Suzuki, Kenichi
    Takiguchi, Tomomi
    Nishio, Makoto
    Koike, Takeshi
    Hayashi, Toshinobu
    Seto, Takashi
    Kogure, Yuki
    Nogami, Naoyuki
    Fujiwara, Kimiko
    Kaneda, Hiroyasu
    Harada, Tomohiko
    Shimizu, Satoru
    Kimura, Masashi
    Kenmotsu, Hirotsugu
    Shimokawa, Mototsugu
    Goto, Koichi
    [J]. BMC PHARMACOLOGY & TOXICOLOGY, 2020, 21 (01):
  • [9] Effectiveness of first-generation 5HT3 receptor antagonist plus dexamethasone plus aprepitant in controlling delayed chemotherapy-induced nausea and vomiting in patients with colorectal cancer: A propensity score-matched analysis
    Hayashi, T.
    Shimokawa, M.
    Matsuo, K.
    Iihara, H.
    Nishimura, J.
    Nakano, T.
    Egawa, T.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [10] Efficacy of thalidomide, neurokinin-1 receptor antagonist, and olanzapine in combination with palonosetron plus dexamethasone in preventing chemotherapy-induced nausea and vomiting (CINV) induced by highly emetogenic chemotherapy (HEC): Bayesian network meta-analysis
    Alhifany, Abdullah
    McBride, Ali
    Almutairi, Abdulaali
    Babiker, Hani M.
    MacDonald, Karen
    Abraham, Ivo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)